NASDAQ:GMVDF G Medical Innovations (GMVDF) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsSEC FilingsTrendsBuy This Stock About G Medical Innovations Stock (NASDAQ:GMVDF) Get G Medical Innovations alerts:Sign Up Key Stats Today's Range N/A50-Day Range N/A52-Week Range N/AVolume10 shsAverage Volume15,560 shsMarket Capitalization$26 thousandP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview G Medical Innovations is an Israel-based medical technology company focused on the design, development and commercialization of mobile health monitoring devices and telehealth solutions. The company’s core business centers on providing easy-to-use, portable electrocardiogram (ECG) recorders that enable healthcare professionals and patients to perform clinical-grade cardiac testing outside of traditional clinical settings. By integrating proprietary sensor hardware with secure software platforms, G Medical Innovations aims to streamline remote patient monitoring and chronic disease management. The company’s flagship product is a wearable, single-lead ECG device that communicates wirelessly with a smartphone or tablet application. This solution offers real-time data transmission and cloud-based storage, allowing clinicians to view, analyze and share patient readings instantly. G Medical Innovations holds clearance from the U.S. Food and Drug Administration (FDA) for its ECG device and has pursued regulatory approvals in several international markets, supporting both ambulatory and in-home cardiac care. Founded in 2006 and headquartered in Airport City, Israel, G Medical Innovations serves a global customer base that includes hospitals, clinics, telemedicine providers and individual consumers. The company has established distribution partnerships across North America, Europe and Asia, positioning its products for use in remote monitoring programs and virtual care platforms. Under the leadership of CEO Zvika Orr, G Medical Innovations leverages a management team with deep expertise in medical device development, regulatory affairs and digital health. AI Generated. May Contain Errors. Read More Receive GMVDF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for G Medical Innovations and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. GMVDF Stock News HeadlinesGMVDF G Medical Innovations Holdings LtdJune 21, 2025 | seekingalpha.comG Medical Innovations Holdings Ltd. (GMVDF)April 18, 2025 | nasdaq.comTicker Revealed: Pre-IPO Access to "Next Elon Musk" CompanyWe’ve found The Next Elon Musk… and what we believe to be the next Tesla. It’s already racked up $26 billion in government contracts. Peter Thiel just bet $1 Billion on it.June 15 at 1:00 AM | Banyan Hill Publishing (Ad)Google Cloud, DeliverHealth partner to enhance medical documentation using AINovember 9, 2024 | msn.comExploring the G:Box and for high-quality imagingNovember 5, 2024 | msn.comG Medical Innovations Announces First Half 2023 Financial Results and Provides Business UpdateJanuary 10, 2024 | stockhouse.comSee More Headlines GMVDF Stock Analysis - Frequently Asked Questions How do I buy shares of G Medical Innovations? Shares of GMVDF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Today6/15/2026Fiscal Year End12/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical & medical instruments Sub-IndustryMedical Equipment Current SymbolNASDAQ:GMVDF CIK1760764 Webgmedinnovations.com Phone972-8-958-4777FaxN/AEmployees72Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual Sales$4.42 million Price / Sales0.00 Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares259,918,000Free Float163,488,000Market Cap$26 thousand OptionableNot Optionable Beta27.28 7 Stocks to Buy And Hold ForeverClick the link to see MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free Report This page (NASDAQ:GMVDF) was last updated on 6/15/2026 by MarketBeat.com Staff. From Our PartnersThe 1934 playbookIn 1934, a legal government maneuver transferred billions in wealth overnight. Most Americans never saw it com...American Alternative | SponsoredTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredTrump Takes Emergency Action - Plus Elon Musk's New VentureElon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...Altimetry | SponsoredIs SpaceX really worth 1.78 Trillion?With SpaceX approaching a near-$2 trillion valuation, most investors are focused on the IPO itself - but analy...InvestPub | SponsoredHey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...Banyan Hill Publishing | SponsoredCODE RED: AI Meltdown Imminent?After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...Paradigm Press | SponsoredSpaceX is chump change compared to Elon’s $20T ‘iPhone’Early Apple investors saw peak gains as high as 7,537% after the iPhone launched. Now, multiple insider source...StocksToTrade | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding G Medical Innovations Holdings Ltd Please log in to your account or sign up in order to add this asset to your watchlist. Share G Medical Innovations With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.